Results 251 to 260 of about 96,147 (311)
Some of the next articles are maybe not open access.
Related searches:
Related searches:
Clinics in Liver Disease, 2019
Portal hypertension (PH) is a clinical syndrome resulting from the combination of increased portal blood flow and increased portal resistance and characterized by an increase in the portosystemic gradient beyond the physiological value of 5 mmHg. PH is a common complication in patients with chronic liver disease, both adults and children, and its major
Di Giorgio A., D'Antiga L.
openaire +3 more sources
Portal hypertension (PH) is a clinical syndrome resulting from the combination of increased portal blood flow and increased portal resistance and characterized by an increase in the portosystemic gradient beyond the physiological value of 5 mmHg. PH is a common complication in patients with chronic liver disease, both adults and children, and its major
Di Giorgio A., D'Antiga L.
openaire +3 more sources
Current Opinion in Gastroenterology, 2009
Portal hypertension is the most common complication of cirrhosis accounting for significant morbidity and mortality mainly because of variceal hemorrhage, ascites, bacterial infections, hepatic encephalopathy, and hepatorenal syndrome. Advances in the diagnosis and management of portal hypertension over the last year are reviewed.The measurement of the
Andrés, Cárdenas, Pere, Ginès
openaire +2 more sources
Portal hypertension is the most common complication of cirrhosis accounting for significant morbidity and mortality mainly because of variceal hemorrhage, ascites, bacterial infections, hepatic encephalopathy, and hepatorenal syndrome. Advances in the diagnosis and management of portal hypertension over the last year are reviewed.The measurement of the
Andrés, Cárdenas, Pere, Ginès
openaire +2 more sources
Clinics in Liver Disease, 2001
Many advances in the management of portal hypertension and variceal hemorrhage have occurred during the last 10 years. Effective therapy for primary prevention of variceal hemorrhage is now available in the form of nonselective beta-blockers. Active bleeding should be managed with terlipressin, somatostatin or its analogues, and endoscopic therapy ...
N, Garcia, A J, Sanyal
openaire +2 more sources
Many advances in the management of portal hypertension and variceal hemorrhage have occurred during the last 10 years. Effective therapy for primary prevention of variceal hemorrhage is now available in the form of nonselective beta-blockers. Active bleeding should be managed with terlipressin, somatostatin or its analogues, and endoscopic therapy ...
N, Garcia, A J, Sanyal
openaire +2 more sources
Portal Hypertensive Gastropathy
Baillière's Clinical Gastroenterology, 1991There is now substantial clinical evidence to suggest that portal hypertensive gastropathy is an important source of gastrointestinal bleeding in patients with portal hypertension. Although a relatively uncommon presenting feature in such patients, it appears to become progressively more frequent and important the longer such patients with bleeding ...
R M, Pérez-Ayuso, J M, Piqué
openaire +4 more sources